Heart rate reserve is a long-term risk predictor in women undergoing myocardial perfusion imaging.


Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 09 02 2019
accepted: 29 04 2019
pubmed: 30 6 2019
medline: 15 9 2020
entrez: 30 6 2019
Statut: ppublish

Résumé

Although women with cardiovascular disease experience relatively worse outcomes as compared to men, substantial knowledge gaps remain regarding the unique female determinants of cardiovascular risk. Heart rate (HR) responses to vasodilator stress mirror autonomic activity and may carry important long-term prognostic information in women. Hemodynamic changes during adenosine stress were recorded in a total of 508 consecutive patients (104 women) undergoing clinically indicated Blunted HRR to adenosine stress adds incremental prognostic value for long-term cardiovascular outcomes in women beyond that provided by traditional risk factors and imaging findings.

Sections du résumé

BACKGROUND BACKGROUND
Although women with cardiovascular disease experience relatively worse outcomes as compared to men, substantial knowledge gaps remain regarding the unique female determinants of cardiovascular risk. Heart rate (HR) responses to vasodilator stress mirror autonomic activity and may carry important long-term prognostic information in women.
METHODS AND RESULTS RESULTS
Hemodynamic changes during adenosine stress were recorded in a total of 508 consecutive patients (104 women) undergoing clinically indicated
CONCLUSION CONCLUSIONS
Blunted HRR to adenosine stress adds incremental prognostic value for long-term cardiovascular outcomes in women beyond that provided by traditional risk factors and imaging findings.

Identifiants

pubmed: 31254034
doi: 10.1007/s00259-019-04344-1
pii: 10.1007/s00259-019-04344-1
doi:

Substances chimiques

Nitrogen Radioisotopes 0
Radiopharmaceuticals 0
Vasodilator Agents 0
Adenosine K72T3FS567

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2032-2041

Subventions

Organisme : Helmut Horten Foundation
ID : research grant
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : research grant
Organisme : Novartis Stiftung für Medizinisch-Biologische Forschung
ID : research grant
Organisme : Olga Mayenfisch Foundation
ID : research grant
Organisme : OPO Foundation
ID : research grant
Organisme : Schweizerische Herzstiftung
ID : research grant
Organisme : Iten-Kohaut Foundation
ID : research grant

Références

Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, Flather M, et al. European Society of Cardiology: cardiovascular disease statistics 2017. Eur Heart J. 2018;39(7):508–79.
doi: 10.1093/eurheartj/ehx628 pubmed: 29190377
Wilmot KA, O’Flaherty M, Capewell S, Ford ES, Vaccarino V. Coronary heart disease mortality declines in the United States from 1979 through 2011: evidence for stagnation in young adults, especially women. Circulation. 2015;132(11):997–1002.
doi: 10.1161/CIRCULATIONAHA.115.015293 pubmed: 26302759 pmcid: 4828724
Murthy VL, Naya M, Taqueti VR, Foster CR, Gaber M, Hainer J, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129(24):2518–27.
doi: 10.1161/CIRCULATIONAHA.113.008507 pubmed: 24787469 pmcid: 4076200
Pepine CJ, Ferdinand KC, Shaw LJ, Light-McGroary KA, Shah RU, Gulati M, et al. Emergence of nonobstructive coronary artery disease: a woman’s problem and need for change in definition on angiography. J Am Coll Cardiol. 2015;66(17):1918–33.
doi: 10.1016/j.jacc.2015.08.876 pubmed: 26493665 pmcid: 4618799
Reis SE, Holubkov R, Conrad Smith AJ, Kelsey SF, Sharaf BL, Reichek N, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001;141(5):735–41.
doi: 10.1067/mhj.2001.114198 pubmed: 11320360
Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35(17):1101–11.
doi: 10.1093/eurheartj/eht513 pubmed: 24366916
Gebhard C, Fiechter M, Herzog BA, Lohmann C, Bengs S, Treyer V, et al. Sex differences in the long-term prognostic value of (13)N-ammonia myocardial perfusion positron emission tomography. Eur J Nucl Med Mol Imaging. 2018;45(11):1964–1974.
Wilkinson C, Bebb O, Dondo TB, Munyombwe T, Casadei B, Clarke S, et al. Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study. Heart. 2018;105(7):516–523.
Mieres JH, Gulati M, Bairey Merz N, Berman DS, Gerber TC, Hayes SN, et al. Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation. 2014;130(4):350–79.
doi: 10.1161/CIR.0000000000000061 pubmed: 25047587
Burger IA, Lohmann C, Messerli M, Bengs S, Becker A, Marędziak M, et al. Age- and sex-dependent changes in sympathetic activity of the left ventricular apex assessed by 18F-DOPA PET imaging. PLoS One. 2018;13(8):e0202302.
doi: 10.1371/journal.pone.0202302 pubmed: 30106984 pmcid: 6091960
Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929–38.
doi: 10.1056/NEJMoa1406761 pubmed: 26332547
La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) investigators. Lancet. 1998;351(9101):478–84.
doi: 10.1016/S0140-6736(97)11144-8 pubmed: 9482439
Hedqvist P, Fredholm BB. Inhibitory effect of adenosine on adrenergic neuroeffector transmission in the rabbit heart. Acta Physiol Scand. 1979;105(1):120–2.
doi: 10.1111/j.1748-1716.1979.tb06321.x pubmed: 420012
Hage FG, Heo J, Franks B, Belardinelli L, Blackburn B, Wang W, et al. Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus. Am Heart J. 2009;157(4):771–6.
doi: 10.1016/j.ahj.2009.01.011 pubmed: 19332209
Fiechter M, Gebhard C, Ghadri JR, Fuchs TA, Pazhenkottil AP, Nkoulou RN, et al. Myocardial perfusion imaging with 13N-ammonia PET is a strong predictor for outcome. Int J Cardiol. 2013;167(3):1023–6.
doi: 10.1016/j.ijcard.2012.03.076 pubmed: 22475847
Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54(2):150–6.
doi: 10.1016/j.jacc.2009.02.069 pubmed: 19573732
Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124(20):2215–24.
doi: 10.1161/CIRCULATIONAHA.111.050427 pubmed: 22007073 pmcid: 3495106
Hage FG, Dean P, Iqbal F, Heo J, Iskandrian AE. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging. J Nucl Cardiol. 2011;18(6):1086–94.
doi: 10.1007/s12350-011-9429-1 pubmed: 21785922
Bhatheja R, Francis GS, Pothier CE, Lauer MS. Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms. Am J Cardiol. 2005;95(10):1159–64.
doi: 10.1016/j.amjcard.2005.01.042 pubmed: 15877986
Abidov A, Hachamovitch R, Hayes SW, Ng CK, Cohen I, Friedman JD, et al. Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study. Circulation. 2003;107(23):2894–9.
doi: 10.1161/01.CIR.0000072770.27332.75 pubmed: 12796141
Amanullah AM, Berman DS, Erel J, Kiat H, Cohen I, Germano G, et al. Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol. 1998;82(6):725–30.
doi: 10.1016/S0002-9149(98)00463-9 pubmed: 9761081
Gebhard C, Messerli M, Lohmann C, Treyer V, Bengs S, Benz DC, et al. Sex and age differences in the association of heart rate responses to adenosine and myocardial ischemia in patients undergoing myocardial perfusion imaging. J Nucl Cardiol. 2018.
Bravo PE, Hage FG, Woodham RM, Heo J, Iskandrian AE. Heart rate response to adenosine in patients with diabetes mellitus and normal myocardial perfusion imaging. Am J Cardiol. 2008;102(8):1103–6.
doi: 10.1016/j.amjcard.2008.06.021 pubmed: 18929717
Ogilby JD, Iskandrian AS, Untereker WJ, Heo J, Nguyen TN, Mercuro J. Effect of intravenous adenosine infusion on myocardial perfusion and function. Hemodynamic/angiographic and scintigraphic study. Circulation. 1992;86(3):887–95.
doi: 10.1161/01.CIR.86.3.887 pubmed: 1516201
Vashist A, Heller EN, Blum S, Brown EJ, Bhalodkar NC. Association of heart rate response with scan and left ventricular function on adenosine myocardial perfusion imaging. Am J Cardiol. 2002;89(2):174–7.
doi: 10.1016/S0002-9149(01)02196-8 pubmed: 11792338
Johnston DL, Daley JR, Hodge DO, Hopfenspirger MR, Gibbons RJ. Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2,000 patients. Mayo Clin Proc. 1995;70(4):331–6.
doi: 10.4065/70.4.331 pubmed: 7898137
Conradson TB, Clarke B, Dixon CM, Dalton RN, Barnes PJ. Effects of adenosine on autonomic control of heart rate in man. Acta Physiol Scand. 1987;131(4):525–31.
doi: 10.1111/j.1748-1716.1987.tb08272.x pubmed: 3327362
Tenan MS, Brothers RM, Tweedell AJ, Hackney AC, Griffin L. Changes in resting heart rate variability across the menstrual cycle. Psychophysiology. 2014;51(10):996–1004.
doi: 10.1111/psyp.12250 pubmed: 24942292
Vongpatanasin W, Tuncel M, Mansour Y, Arbique D, Victor RG. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation. 2001;103(24):2903–8.
doi: 10.1161/01.CIR.103.24.2903 pubmed: 11413078
Liu CC, Kuo TB, Yang CC. Effects of estrogen on gender-related autonomic differences in humans. Am J Physiol Heart Circ Physiol. 2003;285(5):H2188–93.
doi: 10.1152/ajpheart.00256.2003 pubmed: 12881217
Dean J, Cruz SD, Mehta PK, Merz CN. Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy. Nat Rev Cardiol. 2015;12(7):406–14.
doi: 10.1038/nrcardio.2015.72 pubmed: 26011377
Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, lung and blood institute WISE (Women’s ischemia syndrome evaluation) study. J Am Coll Cardiol. 2010;55(25):2825–32.
doi: 10.1016/j.jacc.2010.01.054 pubmed: 20579539 pmcid: 2898523
Tomiyama T, Kumita S, Ishihara K, Suda M, Sakurai M, Hakozaki K, et al. Patients with reduced heart rate response to adenosine infusion have low myocardial flow reserve in (13)N-ammonia PET studies. Int J Cardiovasc Imaging. 2015;31(5):1089–95.
doi: 10.1007/s10554-015-0654-6 pubmed: 25846547 pmcid: 4446519
Haider A, Bengs S, Marędziak M, Messerli M, Fiechter M, Giannopoulos AA, et al. Heart rate reserve during pharmacological stress is a significant negative predictor of impaired coronary flow reserve in women. Eur J Nucl Med Mol Imaging. 2019;46(6):1257–1267.
Zaffalon Junior JR, Viana AO, de Melo GEL, De Angelis K. The impact of sedentarism on heart rate variability (HRV) at rest and in response to mental stress in young women. Physiol Rep. 2018;6(18):e13873.
doi: 10.14814/phy2.13873 pubmed: 30238692 pmcid: 6148327
Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97(6):535–43.
doi: 10.1161/01.CIR.97.6.535 pubmed: 9494023
Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res. 2001;50(1):151–61.
doi: 10.1016/S0008-6363(01)00202-4 pubmed: 11282088

Auteurs

Caroline E Gebhard (CE)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Department of Anesthesiology, University Hospital Basel, Basel, Switzerland.

Monika Marędziak (M)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.

Angela Portmann (A)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.

Susan Bengs (S)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.

Ahmed Haider (A)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.

Michael Fiechter (M)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.

Bernhard A Herzog (BA)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Michael Messerli (M)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Valerie Treyer (V)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Ken Kudura (K)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Elia von Felten (E)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Dominik C Benz (DC)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Tobias A Fuchs (TA)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Christoph Gräni (C)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Aju P Pazhenkottil (AP)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Ronny R Buechel (RR)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Philipp A Kaufmann (PA)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Catherine Gebhard (C)

Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. Catherine.gebhard@usz.ch.
Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland. Catherine.gebhard@usz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH